<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="hyperek" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">hyperek</book-part-id>
      <title-group>
        <title>Hyperekplexia</title>
        <alt-title alt-title-type="alt-title">Synonyms: Hyperekplexia, Hereditary; Startle Disease, Familial; Startle Syndrome</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tijssen</surname>
            <given-names>Marina AJ</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Department of Neurology <break/>University Medical Center Groningen<break/>Groningen, Netherlands</aff>
          <email>m.a.j.de.koning-tijssen@umcg.nl</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rees</surname>
            <given-names>Mark I</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Director, Wales Epilepsy Research Network <break/>School of Medicine <break/>Swansea University<break/>Swansea, Wales, United Kingdom</aff>
          <email>m.i.rees@swansea.ac.uk</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>31</day>
          <month>7</month>
          <year>2007</year>
        </date>
        <date date-type="updated">
          <day>4</day>
          <month>10</month>
          <year>2012</year>
        </date>
        <date date-type="revised">
          <day>19</day>
          <month>5</month>
          <year>2009</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="sys-h" document-type="chapter">Hyalinosis, Inherited Systemic</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="hyper-pp" document-type="chapter">Hyperkalemic Periodic Paralysis</related-object>
      <abstract id="hyperek.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Hereditary hyperekplexia (HPX) is characterized by generalized stiffness immediately after birth that normalizes during the first years of life; excessive startle reflex (eye blinking and a flexor spasm of the trunk) to unexpected (particularly auditory) stimuli; and a short period of generalized stiffness following the startle response during which voluntary movements are impossible. Exaggerated head-retraction reflex (HRR) consisting of extension of the head followed by violent flexor spasms of limbs and neck muscles elicited by tapping the tip of the nose is observed in most children. Other findings include periodic limb movements in sleep (PLMS) and hypnagogic (occurring when falling asleep) myoclonus. Sudden infant death (SIDS) has been reported. Intellect is usually normal; mild intellectual disability may occur.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of HPX is based on clinical findings. Pathogenic variants in five genes are known to cause HPX. <italic toggle="yes">GLRA1</italic>, encoding glycine receptor subunit &#x003b1;1, accounts for about 80% of HPX. The other genes in which pathogenic variants are causative are: <italic toggle="yes">SLC6A5</italic>, encoding the presynaptic sodium- and chloride-dependent glycine transporter 2 (GlyT2); <italic toggle="yes">GLRB</italic>, encoding glycine receptor subunit beta; <italic toggle="yes">GPHN</italic>, encoding the glycinergic clustering molecule, gephyrin; and <italic toggle="yes">ARHGEF9</italic>, encoding collybistin.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> The drug clonazepam is most effective in reducing symptoms, including stiffness in the neonatal period and stiffness related to the excessive startle reflex; other drugs with variable results include carbamazepine, phenytoin, diazepam, valproate, 5-hydroxytryptophan, piracetam, and phenobarbital. Physical and cognitive therapy may reduce the fear of falling and thereby improve walking.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Clonazepam.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>HPX is inherited in an autosomal dominant, autosomal recessive, or, rarely, X-linked manner. Most individuals diagnosed with autosomal dominant HPX have an affected parent; <italic toggle="yes">de novo</italic> pathogenic variants are rare. Each child of an individual with autosomal dominant HPX has a 50% chance of inheriting the pathogenic variant. The parents of a child with autosomal recessive HPX are obligate heterozygotes and therefore carry one mutated allele. At conception, each sib of an individual with autosomal recessive HPX has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Prenatal testing for most families with hyperekplexia is possible if the pathogenic variant(s) have been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="hyperek.Diagnosis">
        <title>Diagnosis</title>
        <sec id="hyperek.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>Diagnosis of hereditary hyperekplexia (HPX) requires the following three cardinal features:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Generalized stiffness immediately after birth,</bold> normalizing during the first years of life. The stiffness increases with handling and disappears during sleep [<xref ref-type="bibr" rid="hyperek.REF.koningtijssen.2000.1293">Koning-Tijssen &#x00026; Brouwer 2000</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Excessive startle reflex</bold> to unexpected (particularly auditory) stimuli. This excessive startle reflex is present at birth. Consciousness is unaltered during startle responses.</p>
            </list-item>
            <list-item>
              <p><bold>Short period of generalized stiffness following the startle response</bold> during which voluntary movements are impossible. Note: On rare occasion this feature is absent.</p>
            </list-item>
          </list>
          <p>Associated features that may be present but are not essential for the diagnosis of HPX include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Exaggerated head-retraction reflex (HRR). In neonates HRR comprises extension of the head, followed by violent flexor spasms of limbs and neck muscles elicited by tapping the tip of the nose but no other part of the nose, forehead, or face [<xref ref-type="bibr" rid="hyperek.REF.kurczynski.1983.246">Kurczynski 1983</xref>, <xref ref-type="bibr" rid="hyperek.REF.dalla_bernardina.1989">Dalla Bernardina et al 1989</xref>, <xref ref-type="bibr" rid="hyperek.REF.shahar.1991.1073">Shahar et al 1991</xref>]. This response is present when the child is awake or asleep and shows no habituation. In adults only the excessive extension of the head is seen. Note: Some consider the HRR essential for diagnosis [<xref ref-type="bibr" rid="hyperek.REF.rees.2001.267">Rees et al 2001</xref>].</p>
            </list-item>
            <list-item>
              <p>Periodic limb movements in sleep (PLMS) and hypnagogic myoclonus (myoclonus occurring when falling asleep)</p>
            </list-item>
            <list-item>
              <p>Inguinal, umbilical, or epigastric herniae</p>
            </list-item>
            <list-item>
              <p>Congenital dislocation of the hip</p>
            </list-item>
            <list-item>
              <p>Sudden infant death (SIDS)</p>
            </list-item>
            <list-item>
              <p>Normal intelligence in most; mild intellectual disability in some</p>
            </list-item>
          </list>
        </sec>
        <sec id="hyperek.Testing">
          <title>Testing</title>
          <p>In general, all laboratory tests are normal in individuals with HPX, including CT and MRI of the brain.</p>
          <sec id="hyperek.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Genes.</bold> Pathogenic variants in one of the following genes are known to cause HPX:</p>
            <list list-type="bullet">
              <list-item>
                <p><bold><italic toggle="yes">GLRA1</italic>,</bold> the gene encoding the &#x003b1;1 subunit of the glycine receptor, is the major genetic cause of HPX. Dominant and recessive pathogenic variants are identified in many individuals with the familial form of HPX and occasionally in simplex cases (i.e., a single occurrence of HPX in a family). For an overview see <xref ref-type="bibr" rid="hyperek.REF.bakker.2006.513">Bakker et al [2006]</xref>.</p>
              </list-item>
              <list-item>
                <p><bold><italic toggle="yes">SLC6A5</italic>,</bold> the gene encoding the presynaptic sodium- and chloride-dependent glycine transporter 2 (GlyT2), is probably also frequently involved [<xref ref-type="bibr" rid="hyperek.REF.rees.2006.801">Rees et al 2006</xref>].</p>
              </list-item>
              <list-item>
                <p><bold><italic toggle="yes">GLRB</italic>,</bold> the gene encoding glycine receptor subunit beta, has been associated with HPX in one individual, in whom compound heterozygous pathogenic variants were detected [<xref ref-type="bibr" rid="hyperek.REF.rees.2002.853">Rees et al 2002</xref>].</p>
              </list-item>
              <list-item>
                <p><bold><italic toggle="yes">GPHN</italic>,</bold> the gene encoding the glycinergic clustering molecule gephyrin, has been associated with HPX in one person [<xref ref-type="bibr" rid="hyperek.REF.rees.2003.24688">Rees et al 2003</xref>].</p>
              </list-item>
              <list-item>
                <p><bold><italic toggle="yes">ARHGEF9</italic>,</bold> an X-linked gene encoding collybistin, has been associated with HPX in one person [<xref ref-type="bibr" rid="hyperek.REF.harvey.2004.5816">Harvey et al 2004</xref>]. This child also had severe epilepsy and intellectual disability and died at age four years.</p>
              </list-item>
            </list>
            <table-wrap id="hyperek.T.summary_of_molecular_genetic_t" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in Hyperekplexia</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of HPX Attributed to Pathogenic Variants in This Gene&#x000a0;<sup>2</sup></th>
                    <th id="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variants Detected&#x000a0;<sup>3</sup></th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">GLRA1</italic>
                    </td>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Familial: ~80%&#x000a0;<sup>4</sup><break/>Simplex: see footnote 5</td>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants&#x000a0;<sup>7</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">6 persons&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>8</sup></td>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Deletion of exons 1-6 &#x00026; novel deletions&#x000a0;<sup>9,&#x000a0;10</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">SLC6A5</italic>
                    </td>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">8 persons&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Exon &#x00026; whole-gene deletions/duplications&#x000a0;<sup>11</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">GLRB</italic>
                    </td>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">1 person&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>8</sup></td>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Exon &#x00026; whole-gene deletions/duplications&#x000a0;<sup>11</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">GPHN</italic>
                    </td>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">1 person&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">ARHGEF9</italic>
                    </td>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">1 person&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants&#x000a0;<sup>12,&#x000a0;13</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>8</sup></td>
                    <td headers="hd_h_hyperek.T.summary_of_molecular_genetic_t_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Exon &#x00026; whole-gene deletions/duplications&#x000a0;<sup>11</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="hyperek.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="hyperek" object-id="hyperek.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="hyperek.TF.1.2">
                  <label>2. </label>
                  <p>Based on more than 40 unrelated affected individuals</p>
                </fn>
                <fn id="hyperek.TF.1.3">
                  <label>3. </label>
                  <p>See <xref ref-type="sec" rid="hyperek.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
                </fn>
                <fn id="hyperek.TF.1.4">
                  <label>4. </label>
                  <p>The variant detection frequency for <italic toggle="yes">GLRA1</italic> in familial hyperekplexia is high as befits a channelopathy disorder with highly penetrant pathogenic variants. The exact number is unknown, but in individuals with HPX and a first-degree family member with HPX, the variant detection frequency is around 80% [Author, personal experience/unpublished data].</p>
                </fn>
                <fn id="hyperek.TF.1.5">
                  <label>5. </label>
                  <p>The variant detection frequency for all genes among individuals without a family history of HPX averages about 20% overall [<xref ref-type="bibr" rid="hyperek.REF.vergouwe.1997.172">Vergouwe et al 1997</xref>, <xref ref-type="bibr" rid="hyperek.REF.milani.1998.341">Milani et al 1998</xref>, <xref ref-type="bibr" rid="hyperek.REF.rees.2001.267">Rees et al 2001</xref>] and mainly involves compound heterozygotes or homozygotes from consanguineous relationships.</p>
                </fn>
                <fn id="hyperek.TF.1.6">
                  <label>6. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="hyperek.TF.1.7">
                  <label>7. </label>
                  <p>Pathogenic missense and nonsense variants have been identified in autosomal dominant and autosomal recessive HPX.</p>
                </fn>
                <fn id="hyperek.TF.1.8">
                  <label>8. </label>
                  <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
                <fn id="hyperek.TF.1.9">
                  <label>9. </label>
                  <p>Heterozygous carriers of the <italic toggle="yes">GLRA1</italic> exon 1-6 deletion cannot be detected by PCR. Detection requires deletion/duplication analysis. Lack of PCR amplification of exons 1-6 implies presence of a homozygous deletion; confirmation may require deletion/duplication analysis.</p>
                </fn>
                <fn id="hyperek.TF.1.10">
                  <label>10. </label>
                  <p>An individual with autosomal recessive HPX and homozygous deletion of <italic toggle="yes">GLRA1</italic> exons 1-6 was identified [<xref ref-type="bibr" rid="hyperek.REF.brune.1996.989">Brune et al 1996</xref>]. Subsequently, this homozygous deletion was found in several Turkish individuals [<xref ref-type="bibr" rid="hyperek.REF.sir_n.2006.137">Sir&#x000e9;n et al 2006</xref>].</p>
                </fn>
                <fn id="hyperek.TF.1.11">
                  <label>11. </label>
                  <p>No deletions or duplications of <italic toggle="yes">GLRB</italic>, <italic toggle="yes">ARHGEF9</italic>, or <italic toggle="yes">SLC6A5</italic> have been reported to cause hyperekplexia. (Note: By definition, deletion/duplication analysis identifies rearrangements that are not identifiable by sequence analysis of genomic DNA.)</p>
                </fn>
                <fn id="hyperek.TF.1.12">
                  <label>12. </label>
                  <p>Identifies a pathogenic variant in exon 2 reported by <xref ref-type="bibr" rid="hyperek.REF.harvey.2004.5816">Harvey et al [2004]</xref> as well as other as-yet unreported sequence variants</p>
                </fn>
                <fn id="hyperek.TF.1.13">
                  <label>13. </label>
                  <p>Lack of amplification by PCR prior to sequence analysis can suggest a putative (multi)exon or whole-gene deletion on the X chromosome in affected males; confirmation may require additional testing by deletion/duplication analysis. Sequence analysis of genomic DNA cannot detect deletion of one or more exons or the entire X-linked gene in a heterozygous female.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="hyperek.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>Confirmation of the diagnosis</bold> of HPX relies on molecular genetic testing. Additional imaging prior to molecular genetic testing is not necessary.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single gene testing.</bold> The most common strategy for molecular diagnosis of a proband who meets HPX clinical inclusion criteria is sequencing of <italic toggle="yes">GLRA1</italic> and <italic toggle="yes">SLC6A5</italic>. Sequence analysis of <italic toggle="yes">ARHGEF9</italic> may be considered in males without identified <italic toggle="yes">GLRA1</italic> or <italic toggle="yes">SLC6A5</italic> pathogenic variants, particularly if cognitive impairment and epilepsy are present. If clinical suspicion is strong and the above tests do not reveal a pathogenic change, molecular testing of <italic toggle="yes">GLRB, GPHN,</italic> and <italic toggle="yes">ARHGEF9</italic> can be considered.</p>
            </list-item>
            <list-item>
              <p><bold>Multi-gene testing.</bold> Consider using a hyperekplexia multi-gene panel that includes genes associated with hyperekplexia. These panels vary by methods used and genes included; thus, the ability of a panel to detect a causative pathogenic variant or variants in any given individual also varies.</p>
            </list-item>
          </list>
          <p><bold>Carrier testing for relatives</bold> at risk for autosomal recessive hyperekplexia requires prior identification of the pathogenic variants in the family.</p>
          <p>Note: Carriers are heterozygotes for this autosomal recessive disorder and are not at risk of developing the disorder.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variant(s) in the family.</p>
        </sec>
      </sec>
      <sec id="hyperek.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="hyperek.Clinical_Description">
          <title>Clinical Description</title>
          <p>Hereditary hyperekplexia (HPX) has three cardinal features: excessive startle reflexes, stiffness at birth, and stiffness related to the startle reflex.</p>
          <p><bold>Excessive startle response.</bold> The most striking feature of HPX is the excessive startle response to unexpected (particularly auditory) stimuli. The excessive startle response is present from birth.</p>
          <p>The excessive startle leads to excessive stiffening in the neonate and young infant; however, not all infants with hyperekplexia can be startled during examination [<xref ref-type="bibr" rid="hyperek.REF.gherpelli.1995.114">Gherpelli et al 1995</xref>, <xref ref-type="bibr" rid="hyperek.REF.vergouwe.1997.172">Vergouwe et al 1997</xref>, <xref ref-type="bibr" rid="hyperek.REF.koningtijssen.2000.1293">Koning-Tijssen &#x00026; Brouwer 2000</xref>].</p>
          <p>The frequency of startle responses varies considerably among individuals and over time. Factors that increase the frequency of the startle responses include emotional tension, nervousness, fatigue, and even the expectation of being frightened. Holding objects or drinking alcohol reduces the intensity and frequency of startle responses.</p>
          <p>The excessive startle reflex has major implications for daily life as unexpected stimuli from the outside world cannot be regulated.</p>
          <p><bold>Generalized stiffness immediately after birth.</bold> Generalized stiffness occurs immediately after birth, usually normalizing during the first years of life. The stiffness increases with handling and disappears during sleep. Held horizontally the baby is as "stiff as a stick." The baby is alert, but shows marked hypokinesia [<xref ref-type="bibr" rid="hyperek.REF.koningtijssen.2000.1293">Koning-Tijssen &#x00026; Brouwer 2000</xref>]. Handling a baby, for example when changing diapers, is difficult because spreading of the legs is limited by stiffness. Affected children usually have delayed milestones but catch up later.</p>
          <p><bold>Generalized stiffness following the startle response.</bold> This is a short period during which voluntary movements are impossible [<xref ref-type="bibr" rid="hyperek.REF.bernasconi.1996.447">Bernasconi et al 1996</xref>]; the stiffness is so severe that it prevents the individual, who retains consciousness, from putting out his/her arms to break a fall. Adults with HPX often walk with a stiff-legged, mildly wide-based gait without signs of ataxia.</p>
          <p><bold>Other.</bold> A fourth feature considered to be a hallmark of HPX in stiff newborns and adults [<xref ref-type="bibr" rid="hyperek.REF.rees.2001.267">Rees et al 2001</xref>] is an exaggerated head-retraction reflex (HRR), elicited by tapping on the nose. It has also been described in children with cerebral palsy resulting from severe neonatal asphyxia. Not all adults with HPX have an exaggerated HRR. In daily life persons with HPX note hypersensitivity in the mantle area (the area round the mouth).</p>
          <p>Attacks of tonic neonatal cyanosis have been described in neonates with HPX [<xref ref-type="bibr" rid="hyperek.REF.vergouwe.1997.172">Vergouwe et al 1997</xref>, <xref ref-type="bibr" rid="hyperek.REF.miraglia_del_giudice.2003.e71">Miraglia Del Giudice et al 2003</xref>, <xref ref-type="bibr" rid="hyperek.REF.rees.2006.801">Rees et al 2006</xref>, <xref ref-type="bibr" rid="hyperek.REF.rivera.2006.104">Rivera et al 2006</xref>]. These attacks can be associated with SIDS. Attacks of tonic neonatal cyanosis often resolve during infancy [<xref ref-type="bibr" rid="hyperek.REF.rees.2006.801">Rees et al 2006</xref>].</p>
        </sec>
        <sec id="hyperek.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No specific genotype-phenotype correlations are known in HPX.</p>
          <p><xref ref-type="bibr" rid="hyperek.REF.bellini.2007.1947">Bellini et al [2007]</xref> reported a male child with hyperekplexia and a dominant-negative <italic toggle="yes">GLRA1</italic> pathogenic variant that suppressed normal GLRA1 channel function (heterozygous p.Ser296Ter).</p>
          <p>Pathogenic variants in <italic toggle="yes">SLC6A5</italic> may be regarded as a risk factor for attacks of tonic neonatal cyanosis and SIDS. Conversely, attacks of tonic neonatal cyanosis are rarely seen in infants with <italic toggle="yes">GLRA1</italic> pathogenic variants [<xref ref-type="bibr" rid="hyperek.REF.matsumoto.1992.41">Matsumoto et al 1992</xref>].</p>
        </sec>
        <sec id="hyperek.Penetrance">
          <title>Penetrance</title>
          <p>Overall, the penetrance of hyperekplexia is 100%; however, in one family a mother who had the same variant as her two affected children was asymptomatic [<xref ref-type="bibr" rid="hyperek.REF.kwok.2001.e17">Kwok et al 2001</xref>].</p>
        </sec>
        <sec id="hyperek.Anticipation">
          <title>Anticipation</title>
          <p>Anticipation is not observed in HPX.</p>
        </sec>
        <sec id="hyperek.Nomenclature">
          <title>Nomenclature</title>
          <p>Terms used for hyperekplexia in the past that are no longer in use include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Exaggerated startle reaction</p>
            </list-item>
            <list-item>
              <p>Hyperexplexia</p>
            </list-item>
            <list-item>
              <p>Stiff baby syndrome</p>
            </list-item>
            <list-item>
              <p>Stiff person syndrome, congenital</p>
            </list-item>
            <list-item>
              <p>Stiff man syndrome, congenital</p>
            </list-item>
            <list-item>
              <p>Kok disease</p>
            </list-item>
          </list>
          <p>Although the original Dutch family reported [<xref ref-type="bibr" rid="hyperek.REF.suhren.1966.577">Suhren et al 1966</xref>] was said to have a "major form" and a "minor form" consisting solely of a reportedly excessive response to startling stimuli [<xref ref-type="bibr" rid="hyperek.REF.andermann.1980.985">Andermann et al 1980</xref>], it now appears that no genetic entity conforms to the "minor form" [<xref ref-type="bibr" rid="hyperek.REF.tijssen.1995.578">Tijssen et al 1995</xref>, <xref ref-type="bibr" rid="hyperek.REF.tijssen.1996.608">Tijssen et al 1996</xref>, <xref ref-type="bibr" rid="hyperek.REF.crone.2001.190">Crone et al 2001</xref>, <xref ref-type="bibr" rid="hyperek.REF.tijssen.2002.826">Tijssen et al 2002</xref>, <xref ref-type="bibr" rid="hyperek.REF.bakker.2006.513">Bakker et al 2006</xref>] and thus the term is no longer in use. The etiology of the clinically detected "minor form" needs further investigation.</p>
        </sec>
        <sec id="hyperek.Prevalence">
          <title>Prevalence</title>
          <p>Hereditary HPX has been identified in more than 70 pedigrees and many different nationalities.</p>
        </sec>
      </sec>
      <sec id="hyperek.Genetically_Related_Allelic_Diso">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No other phenotypes are associated with mutation of <italic toggle="yes">GLRA1</italic>, <italic toggle="yes">SLC6A5</italic>, or <italic toggle="yes">GLRB.</italic></p>
        <p>
          <bold>
            <italic toggle="yes">ARHGEF9</italic>
          </bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p><xref ref-type="bibr" rid="hyperek.REF.marco.2008.100">Marco et al [2008]</xref> reported a child with intellectual disability, hyperactivity, and sensory hyperarousal (pounding heartbeat, sweating, and active avoidance) especially to noise, who was found to have a paracentric inversion in which the break point disrupted <italic toggle="yes">ARHGEF9</italic>.</p>
          </list-item>
          <list-item>
            <p><xref ref-type="bibr" rid="hyperek.REF.kalscheuer.2009.61">Kalscheuer et al [2009]</xref> reported a female with a balanced chromosomal translocation disrupting <italic toggle="yes">ARHGEF9</italic> associated with epilepsy, anxiety, aggression, and intellectual disability, but not associated with hyperekplexia.</p>
          </list-item>
        </list>
        <p><bold><italic toggle="yes">GPHN.</italic></bold> Pathogenic variants in <italic toggle="yes">GPHN</italic> cause a severe metabolic defect, molybdenum deficiency syndrome (Moco deficiency), which is usually lethal in infancy [<xref ref-type="bibr" rid="hyperek.REF.feng.1998.1321">Feng et al 1998</xref>].</p>
      </sec>
      <sec id="hyperek.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The following three types of disorders need to be considered in a person with excessive startle response (see <xref ref-type="bibr" rid="hyperek.REF.bakker.2006.513">Bakker et al [2006]</xref> for a detailed review).</p>
        <p><bold>Hyperekplexia (HPX)</bold> as described in this <italic toggle="yes">GeneReview</italic> (i.e., with excessive startle response, stiffness related to the startle reflex, and stiffness in the neonatal period) is rarely symptomatic of another disorder. Exceptions:</p>
        <list list-type="bullet">
          <list-item>
            <p>One individual with a similar neonatal phenotype who was determined to have molybdenum cofactor deficiency [<xref ref-type="bibr" rid="hyperek.REF.macaya.2005.389">Macaya et al 2005</xref>] (see <xref ref-type="sec" rid="hyperek.Genetically_Related_Allelic_Diso">Genetically Related Disorders</xref>). Molybdenum cofactor deficiency should be considered in those with apparent HPX who are refractory to treatment with clonazepam.</p>
          </list-item>
          <list-item>
            <p>Those with late onset (i.e., without stiffness in the neonatal period), in whom damage to the brain stem should be considered</p>
          </list-item>
        </list>
        <p><bold>Neuropsychiatric startle syndromes.</bold> In addition to excessive startling, behavioral and/or psychiatric symptoms are observed. Included in this group:</p>
        <list list-type="bullet">
          <list-item>
            <p>Culture-specific syndromes, such as the &#x0201c;jumping Frenchman of Maine,&#x0201d; in which non-habituating hyperstartling occurs within a community, evoked by loud noises or a forceful poke in the side. Following a startle reflex other responses may be seen, including echolalia and echopraxia.</p>
          </list-item>
          <list-item>
            <p>Hysterical jumps, which clinically resemble disorders like latah but are not culture specific</p>
          </list-item>
          <list-item>
            <p>Anxiety disorders</p>
          </list-item>
          <list-item>
            <p>Gilles de la Tourette syndrome, in which an exaggerated startle reflex has been described in some, but not all, affected individuals</p>
          </list-item>
        </list>
        <p><bold>Startle-induced disorders.</bold> In this diverse group of disorders the startle reflex itself is not excessive, but rather induces another clinical feature that is more prominent than the exaggerated startle response. Examples:</p>
        <list list-type="bullet">
          <list-item>
            <p>Startle epilepsy</p>
          </list-item>
          <list-item>
            <p>Reticular and propriospinal myoclonus</p>
          </list-item>
          <list-item>
            <p>Paroxysmal kinesigenic choreoathetosis (see <related-object link-type="booklink" source-id="gene" document-id="pknd" document-type="chapter">Familial Paroxysmal Kinesigenic Dyskinesia</related-object>)</p>
          </list-item>
          <list-item>
            <p>Tic disorders</p>
          </list-item>
          <list-item>
            <p>Creutzfeldt-Jakob disease (see <related-object link-type="booklink" source-id="gene" document-id="prion" document-type="chapter">Prion Disease</related-object>)</p>
          </list-item>
          <list-item>
            <p>Subacute sclerosing panencephalitis</p>
          </list-item>
          <list-item>
            <p>Paraneoplastic syndromes</p>
          </list-item>
        </list>
        <p>Another startle-induced disorder is stiff person syndrome (SPS), characterized by progressive axial stiffness and intermittent spasms that are usually evoked by unexpected stimuli. Onset is generally between ages 40 and 60 years. The combination of stiffness and startle-induced falls closely resembles HPX. The stiffness in SPS is, however, nearly continuous, contrasting sharply with stiffness in adult HPX, which only occurs after a startle and lasts one to two seconds. In SPS, electromyogram of the long back muscles shows continuous muscle activity.</p>
      </sec>
      <sec id="hyperek.Management">
        <title>Management</title>
        <sec id="hyperek.Evaluations_Following_Initial_Di">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with hyperekplexia (HPX), the following are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic examination</p>
            </list-item>
            <list-item>
              <p>Evaluation for the head retraction reflex</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="hyperek.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Clonazepam appears to be the most effective treatment for HPX [<xref ref-type="bibr" rid="hyperek.REF.tijssen.1997.63">Tijssen et al 1997</xref>, <xref ref-type="bibr" rid="hyperek.REF.tsai.2004.893">Tsai et al 2004</xref>]. In adults the initial dose is 0.5 mg twice a day. The dose can be increased up to 2.0 mg three times a day. The stiffness in the neonatal period and stiffness related to startle diminish with the treatment.</p>
          <p>Other drugs, mostly described in case reports, have shown variable results; they include carbamazepine, phenytoin, diazepam, valproate, 5-hydroxytryptophan, piracetam, and phenobarbital. For an overview see <xref ref-type="bibr" rid="hyperek.REF.bakker.2006.513">Bakker et al [2006]</xref>.</p>
          <p>Physical and cognitive therapy to reduce the fear of falling and thereby improve walking can be considered; no randomized trials have assessed the effectiveness of such treatment.</p>
          <p>Attacks of tonic neonatal cyanosis can be stopped by the Vigevano maneuver, consisting of forced flexion of the head and legs towards the trunk [<xref ref-type="bibr" rid="hyperek.REF.vigevano.1989.216">Vigevano et al 1989</xref>].</p>
        </sec>
        <sec id="hyperek.Prevention_of_Primary_Manifestat">
          <title>Prevention of Primary Manifestations</title>
          <p>See <xref ref-type="sec" rid="hyperek.Treatment_of_Manifestations">Treatment of Manifestations</xref>, clonazepam.</p>
        </sec>
        <sec id="hyperek.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="hyperek.Related_Genetic_Counseling_Issue">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="hyperek.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="hyperek.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="hyperek.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Hyperekplexia (HPX) is inherited in an autosomal dominant, autosomal recessive, or (rarely) X-linked manner.</p>
          <p>Note: In simplex cases (i.e., a single occurrence in a family), mode of inheritance is determined by testing the parents of a proband. When the parents are not available, sequence analysis is used to demonstrate biallelic inheritance in compound heterozygotes.</p>
        </sec>
        <sec id="hyperek.Risk_to_Family_Members__Autosoma">
          <title>Risk to Family Members &#x02014; Autosomal Dominant Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Most individuals diagnosed with autosomal dominant HPX have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with autosomal dominant HPX may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant; however, the proportion of cases caused by <italic toggle="yes">de novo</italic> pathogenic variants is very small: only two cases have been described [<xref ref-type="bibr" rid="hyperek.REF.miraglia_del_giudice.2003.e71">Miraglia Del Giudice et al 2003</xref>].</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include molecular genetic testing if the variant has been identified in the proband.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low.</p>
            </list-item>
            <list-item>
              <p>If a pathogenic variant cannot be detected in the DNA of either parent, two possible explanations are germline mosaicism in a parent or a <italic toggle="yes">de novo</italic> pathogenic variant in the proband. Although no instances of germline mosaicism have been reported, it remains a possibility.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with autosomal dominant HPX has a 50% chance of inheriting the pathogenic variant.</p>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the status of the proband's parents: if a parent is affected, his or her family members are at risk.</p>
        </sec>
        <sec id="hyperek.Risk_to_Family_Members__Autosoma_1">
          <title>Risk to Family Members &#x02014; Autosomal Recessive Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes and therefore carry one mutated allele.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) do not exhibit the hyperekplexia phenotype regardless of variant type (i.e., missense or nonsense).</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with autosomal recessive HPX are obligate heterozygotes (carriers) for a pathogenic variant.</p>
        </sec>
        <sec id="hyperek.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk family members is possible once the pathogenic variant(s) have been identified in the proband.</p>
        </sec>
        <sec id="hyperek.Related_Genetic_Counseling_Issue">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant or clinical evidence of the disorder, it is likely that the proband has a <italic toggle="yes">de novo</italic> variant. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="hyperek.Prenatal_Testing_and_Preimplanta">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the pathogenic variant(s) have been identified in an affected family member, prenatal diagnosis for a pregnancy at increased risk and preimplantation genetic diagnosis for hyperekplexia are possible.</p>
        </sec>
      </sec>
      <sec id="hyperek.Resources">
        <title>Resources</title>
      </sec>
      <sec id="hyperek.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p>See <xref ref-type="fig" rid="hyperek.F1">Figure 1</xref>.</p>
        <p>
          <bold>
            <italic toggle="yes">GLRA1</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">GLRA1</italic> comprises nine exons (Reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001146040.1">NM_001146040.1</ext-link>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="hyperek" object-id="hyperek.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> Several missense and nonsense variants have been identified in autosomal dominant, recessive, or compound heterozygote hyperekplexia (HPX). Pathogenic variants of <italic toggle="yes">GLRA1</italic> in the public domain are summarized in <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="hyperek-Table2.pdf" content-type="local-data">Table 2</inline-supplementary-material> (pdf).</p>
        <p><xref ref-type="bibr" rid="hyperek.REF.sir_n.2006.137">Sir&#x000e9;n et al [2006]</xref> reported six affected individuals from two consanguineous Kurdish families from Turkey with HPX resulting from a homozygous deletion of the first seven <italic toggle="yes">GLRA1</italic> exons, suggesting a founder variant in this population.</p>
        <p><bold>Normal gene product.</bold>
<italic toggle="yes">GLRA1</italic> encodes alpha-1 subunit of the inhibitory glycine receptor. See <xref ref-type="fig" rid="hyperek.F1">Figure 1</xref>.</p>
        <p><bold>Abnormal gene product.</bold> In <italic toggle="yes">GLRA1</italic> the abnormal gene products are categorized as missense or nonsense. Missense variants cause biophysical alterations in the properties of the glycine channel which often lead to compromised channel dynamics.</p>
        <p>In contrast to murine models of the disease, deletions in <italic toggle="yes">GLRA1</italic> that are null variants are not lethal in humans.</p>
        <p>In GlyT2 the transporter functions are knocked out by a process of nonsense-mediated decay, disruption of the glycine uptake, or inhibition of Na<sup>+</sup> ion coactivation.</p>
        <p>
          <bold>
            <italic toggle="yes">GLRB</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">GLRB</italic> has ten exons (Reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000824.4">NM_000824.4</ext-link>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="hyperek" object-id="hyperek.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> Pathogenic variants of <italic toggle="yes">GLRB</italic> in the public domain are summarized in <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="hyperek-Tables3-5.pdf" content-type="local-data">Table 3</inline-supplementary-material> (pdf).</p>
        <p><bold>Normal gene product.</bold>
<italic toggle="yes">GLRB</italic> encodes glycine receptor subunit beta, which is composed of 497 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000815.1">NP_000815.1</ext-link>). See <xref ref-type="fig" rid="hyperek.F1">Figure 1</xref>.</p>
        <p><bold>Abnormal gene product.</bold> See <xref ref-type="fig" rid="hyperek.F1">Figure 1</xref>.</p>
        <p>
          <bold>
            <italic toggle="yes">SLC6A5</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">SLC6A5</italic> has 16 exons (Reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_004211.3">NM_004211.3</ext-link>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="hyperek" object-id="hyperek.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> Pathogenic variants of <italic toggle="yes">SLC6A5</italic> in the public domain are summarized in <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="hyperek-Tables3-5.pdf" content-type="local-data">Table 4</inline-supplementary-material> (pdf).</p>
        <p><bold>Normal gene product.</bold>
<italic toggle="yes">SLC6A5</italic> encodes sodium- and chloride-dependent glycine transporter 2, which has 797 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_004202.2">NP_004202.2</ext-link>).</p>
        <p><bold>Abnormal gene product.</bold> See <xref ref-type="fig" rid="hyperek.F1">Figure 1</xref>.</p>
        <p>
          <bold>
            <italic toggle="yes">GPHN</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">GPHN</italic> has 23 exons (Reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_020806.4">NM_020806.4</ext-link>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="hyperek" object-id="hyperek.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> Pathogenic variants of <italic toggle="yes">GPHN</italic> in the public domain are summarized in <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="hyperek-Tables3-5.pdf" content-type="local-data">Table 5</inline-supplementary-material> (pdf).</p>
        <p><bold>Normal gene product.</bold> Gephyrin, a pleiotropic protein with both a postsynaptic and metabolic biologic role, comprises 769 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_065857.1">NP_065857.1</ext-link>).</p>
        <p><bold>Abnormal gene product.</bold> See <xref ref-type="fig" rid="hyperek.F1">Figure 1</xref>.</p>
        <p>
          <bold>
            <italic toggle="yes">ARHGEF9</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">ARHGEF9</italic> has ten exons (Reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_015185.2">NM_015185.2</ext-link>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="hyperek" object-id="hyperek.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> Pathogenic alleles appear to disrupt interaction of collybistin with other important signaling proteins [<xref ref-type="bibr" rid="hyperek.REF.harvey.2004.5816">Harvey et al 2004</xref>]. See <related-object source-id="gene" document-id="hyperek" object-id="hyperek.molgen.TA">Table A</related-object>.</p>
        <p><bold>Normal gene product.</bold> Collybistin, also known as rho guanine nucleotide exchange factor 9, belongs to a family of regulators involved in cell signaling. The brain-specific collybistin interacts with gephyrin and subsequently regulates actin cytoskeleton dynamics.</p>
        <p><bold>Abnormal gene product.</bold> See <xref ref-type="fig" rid="hyperek.F1">Figure 1</xref>.</p>
      </sec>
      <sec id="hyperek.References">
        <title>References</title>
        <sec id="hyperek.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="hyperek.Literature_Cited.reflist0">
            <ref id="hyperek.REF.andermann.1980.985">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keene</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quesney</surname>
                    <given-names>LF</given-names>
                  </name>
                </person-group>
                <year>1980</year>
                <article-title>Startle disease or hyperekplexia: further delineation of the syndrome.</article-title>
                <source>Brain</source>
                <volume>103</volume>
                <fpage>985</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">6777025</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.bakker.2006.513">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bakker</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Dijk</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tijssen</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Startle syndromes.</article-title>
                <source>Lancet Neurol</source>
                <volume>5</volume>
                <fpage>513</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">16713923</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.bellini.2007.1947">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bellini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miceli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mangano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miraglia del Giudice</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coppola</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbagallo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taglialatela</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascotto</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Hyperekplexia caused by dominant-negative suppression of GLYRA1 function.</article-title>
                <source>Neurology</source>
                <volume>68</volume>
                <fpage>1947</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17536053</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.bernasconi.1996.447">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bernasconi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Regli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schorderet</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pescia</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Familial hyperekplexia: startle disease. Clinical, electrophysiological and genetic study of a family.</article-title>
                <source>Rev Neurol (Paris)</source>
                <volume>152</volume>
                <fpage>447</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">8944241</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.brune.1996.989">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brune</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saul</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Knebel Doeberitz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grond-Ginsbach</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kellerman</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meinck</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>CM</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>A GLRA1 null mutation in recessive hyperekplexia challenges the functional role of glycine receptors.</article-title>
                <source>Am J Hum Genet</source>
                <volume>58</volume>
                <fpage>989</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">8651283</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.crone.2001.190">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Crone</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nielsen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petersen</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tijssen</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Dijk</surname>
                    <given-names>JG</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Patients with the major and minor form of hyperekplexia differ with regards to disynaptic reciprocal inhibition between ankle flexor and extensor muscles.</article-title>
                <source>Exp Brain Res</source>
                <volume>140</volume>
                <fpage>190</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11521151</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.dalla_bernardina.1989">
              <mixed-citation publication-type="book">Dalla Bernardina B, Fontana E, Colamaria V, La Selva L, Merlin D, Sgro V, Scarpa P. Neonatal hyperexplexia. In: Beaumanoir A, Gastaut H, Naquet R, eds. <italic toggle="yes">Reflex Seizures and Reflex Epilepsies</italic>. Geneva, Switzerland: Editions M&#x000e9;dicine et Hygi&#x000e8;ne; 1989:409-14.</mixed-citation>
            </ref>
            <ref id="hyperek.REF.feng.1998.1321">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tintrup</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirsch</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nichol</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuhse</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Betz</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanes</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Dual requirement for gephyrin in glycine receptor clustering and molybdoenzyme activity.</article-title>
                <source>Science.</source>
                <volume>282</volume>
                <fpage>1321</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">9812897</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.gherpelli.1995.114">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gherpelli</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nogueira</surname>
                    <given-names>AR</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Troster</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deutsch</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leone</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brotto</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diament</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramos</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Hyperekplexia, a cause of neonatal apnea: a case report.</article-title>
                <source>Brain Dev</source>
                <volume>17</volume>
                <fpage>114</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">7625544</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.harvey.2004.5816">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Harvey</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duguid</surname>
                    <given-names>IC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alldred</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beatty</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keep</surname>
                    <given-names>NH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lingenfelter</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearce</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lundgren</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Owen</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smart</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luscher</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rees</surname>
                    <given-names>MI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harvey</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The GDP-GTP exchange factor collybistin: an essential determinant of neuronal gephyrin clustering.</article-title>
                <source>J Neurosci</source>
                <volume>24</volume>
                <fpage>5816</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">15215304</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.kalscheuer.2009.61">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kalscheuer</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Musante</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fang</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuchs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carta</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deas</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venkateswarlu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menzel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ullmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tommerup</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalpr&#x000e0;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tzschach</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selicorni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000fc;scher</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ropers</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harvey</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harvey</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardation.</article-title>
                <source>Hum Mutat.</source>
                <volume>30</volume>
                <fpage>61</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18615734</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.koningtijssen.2000.1293">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koning-Tijssen</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brouwer</surname>
                    <given-names>OF</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Hyperekplexia in the first year of life.</article-title>
                <source>Mov Disord</source>
                <volume>15</volume>
                <fpage>1293</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11104232</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.kurczynski.1983.246">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kurczynski</surname>
                    <given-names>TW</given-names>
                  </name>
                </person-group>
                <year>1983</year>
                <article-title>Hyperekplexia.</article-title>
                <source>Arch Neurol</source>
                <volume>40</volume>
                <fpage>246</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">6830476</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.kwok.2001.e17">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kwok</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raskin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antoniuk</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruk</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schofield</surname>
                    <given-names>PR</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Mutations in the glycine receptor alpha1 subunit (GLRA1) gene in hereditary hyperekplexia pedigrees: evidence for non-penetrance of mutation Y279C.</article-title>
                <source>J Med Genet</source>
                <volume>38</volume>
                <fpage>E17</fpage>
                <pub-id pub-id-type="pmid">11389164</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.macaya.2005.389">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Macaya</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunso</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fernandez-Castillo</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arranz</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ginjaar</surname>
                    <given-names>HB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cuenca-Leon</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corominas</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roig</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormand</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Molybdenum cofactor deficiency presenting as neonatal hyperekplexia: a clinical, biochemical and genetic study.</article-title>
                <source>Neuropediatrics</source>
                <volume>36</volume>
                <fpage>389</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">16429380</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.marco.2008.100">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marco</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abidi</surname>
                    <given-names>FE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bristow</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dean</surname>
                    <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cotter</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeremy</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sherr</surname>
                    <given-names>EH</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>ARHGEF9 disruption in a female patient is associated with X linked mental retardation and sensory hyperarousal.</article-title>
                <source>J Med Genet.</source>
                <volume>45</volume>
                <fpage>100</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17893116</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.matsumoto.1992.41">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuhr</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nigro</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hallett</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Physiological abnormalities in hereditary hyperekplexia.</article-title>
                <source>Ann Neurol</source>
                <volume>32</volume>
                <fpage>41</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">1642471</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.milani.1998.341">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Milani</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulhardt</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lichter</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kioschis</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poustka</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>CM</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>The human glycine receptor beta subunit gene (GLRB): structure, refined chromosomal localization, and population polymorphism.</article-title>
                <source>Genomics</source>
                <volume>50</volume>
                <fpage>341</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">9676428</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.miraglia_del_giudice.2003.e71">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miraglia Del Giudice</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coppola</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ledaal</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hertz</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascotto</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>A novel mutation (R218Q) at the boundary between the N-terminal and the first transmembrane domain of the glycine receptor in a case of sporadic hyperekplexia.</article-title>
                <source>J Med Genet</source>
                <volume>40</volume>
                <fpage>e71</fpage>
                <pub-id pub-id-type="pmid">12746425</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.rees.2006.801">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rees</surname>
                    <given-names>MI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harvey</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearce</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duguid</surname>
                    <given-names>IC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beatty</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armstrong</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiang</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abbott</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuberi</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephenson</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Owen</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tijssen</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smart</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Supplisson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harvey</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease.</article-title>
                <source>Nat Genet</source>
                <volume>38</volume>
                <fpage>801</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16751771</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.rees.2003.24688">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rees</surname>
                    <given-names>MI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harvey</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duguid</surname>
                    <given-names>IC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsu</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coleman</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waldvogel</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibbon</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smart</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Owen</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harvey</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snell</surname>
                    <given-names>RG</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Isoform heterogeneity of the human gephyrin gene (GPHN), binding domains to the glycine receptor, and mutation analysis in hyperekplexia.</article-title>
                <source>J Biol Chem</source>
                <volume>278</volume>
                <fpage>24688</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">12684523</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.rees.2002.853">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rees</surname>
                    <given-names>MI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwok</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Govaert</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snell</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schofield</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Owen</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Hyperekplexia associated with compound heterozygote mutations in the beta-subunit of the human inhibitory glycine receptor (GLRB).</article-title>
                <source>Hum Mol Genet</source>
                <volume>11</volume>
                <fpage>853</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">11929858</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.rees.2001.267">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rees</surname>
                    <given-names>MI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vafa</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrie</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corry</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephenson</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerr</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snell</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schofield</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Owen</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Compound heterozygosity and nonsense mutations in the alpha(1)-subunit of the inhibitory glycine receptor in hyperekplexia.</article-title>
                <source>Hum Genet</source>
                <volume>109</volume>
                <fpage>267</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">11702206</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.rivera.2006.104">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rivera</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villega</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Saint-Martin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Escande</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaigne</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Astruc</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Congenital hyperekplexia: five sporadic cases.</article-title>
                <source>Eur J Pediatr</source>
                <volume>165</volume>
                <fpage>104</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16211400</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.shahar.1991.1073">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shahar</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brand</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uziel</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barak</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Nose tapping test inducing a generalized flexor spasm: a hallmark of hyperexplexia.</article-title>
                <source>Acta Paediatr Scand</source>
                <volume>80</volume>
                <fpage>1073</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">1750341</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.sir_n.2006.137">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sir&#x000e9;n</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legros</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chahine</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mission</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pandolfo</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Hyperekplexia in Kurdish families: a possible GLRA1 founder mutation.</article-title>
                <source>Neurology</source>
                <volume>67</volume>
                <fpage>137</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16832093</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.suhren.1966.577">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Suhren</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruyn</surname>
                    <given-names>GW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuynman</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1966</year>
                <article-title>Hyperexplexia, a hereditary startle syndrome.</article-title>
                <source>J Neurol Sci</source>
                <volume>3</volume>
                <fpage>577</fpage>
                <lpage>605</lpage>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.tijssen.1996.608">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tijssen</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Padberg</surname>
                    <given-names>GW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Dijk</surname>
                    <given-names>JG</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>The startle pattern in the minor form of hyperekplexia.</article-title>
                <source>Arch Neurol</source>
                <volume>53</volume>
                <fpage>608</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">8929168</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.tijssen.1997.63">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tijssen</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schoemaker</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edelbroek</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roos</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Dijk</surname>
                    <given-names>JG</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>The effects of clonazepam and vigabatrin in hyperekplexia.</article-title>
                <source>J Neurol Sci</source>
                <volume>149</volume>
                <fpage>63</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9168167</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.tijssen.1995.578">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tijssen</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiang</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Deutekom</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boerman</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wasmuth</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandkuijl</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Padberg</surname>
                    <given-names>GW</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Molecular genetic reevaluation of the Dutch hyperekplexia family.</article-title>
                <source>Arch Neurol</source>
                <volume>52</volume>
                <fpage>578</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">7763205</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.tijssen.2002.826">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tijssen</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vergouwe</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Dijk</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rees</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Major and minor form of hereditary hyperekplexia.</article-title>
                <source>Mov Disord</source>
                <volume>17</volume>
                <fpage>826</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">12210885</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.tsai.2004.893">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tsai</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>FC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Su</surname>
                    <given-names>YC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsai</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuo</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>YW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>CS</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Two novel mutations of the glycine receptor gene in a Taiwanese hyperekplexia family.</article-title>
                <source>Neurology</source>
                <volume>63</volume>
                <fpage>893</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15365143</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.vergouwe.1997.172">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vergouwe</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tijssen</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiang</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Dijk</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>al Shahwan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ophoff</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Hyperekplexia-like syndromes without mutations in the GLRA1 gene.</article-title>
                <source>Clin Neurol Neurosurg</source>
                <volume>99</volume>
                <fpage>172</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9350397</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.vigevano.1989.216">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vigevano</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Capua</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalla Bernardina</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>1989</year>
                <article-title>Startle disease: an avoidable cause of sudden infant death.</article-title>
                <source>Lancet</source>
                <volume>1</volume>
                <fpage>216</fpage>
                <pub-id pub-id-type="pmid">2563117</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="hyperek.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="hyperek.Suggested_Reading.reflist0">
            <ref id="hyperek.REF.breitinger.2002.1042">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Breitinger</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>CM</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>The inhibitory glycine receptor-simple views of a complicated channel.</article-title>
                <source>Chembiochem</source>
                <volume>3</volume>
                <fpage>1042</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">12404628</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.brown.2002.153">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Neurophysiology of the startle syndrome and hyperekplexia.</article-title>
                <source>Adv Neurol</source>
                <volume>89</volume>
                <fpage>153</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11968441</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.eulenburg.2005.325">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eulenburg</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armsen</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Betz</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomeza</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Glycine transporters: essential regulators of neurotransmission.</article-title>
                <source>Trends Biochem Sci</source>
                <volume>30</volume>
                <fpage>325</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">15950877</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.jen">
              <mixed-citation publication-type="book">Jen JC, Pt&#x000e1;&#x0010d;ek L. Channelopathies: episodic disorders of the nervous system. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID).</italic> New York, NY: McGraw-Hill. Chap 204. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/">online</ext-link>.</mixed-citation>
            </ref>
            <ref id="hyperek.REF.lermansagie.2004.522">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lerman-Sagie</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watemberg</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vinkler</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fishhof</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leshinsky-Silver</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lev</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Familial hyperekplexia and refractory status epilepticus: a new autosomal recessive syndrome.</article-title>
                <source>J Child Neurol</source>
                <volume>19</volume>
                <fpage>522</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15526957</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.lynch.2004.1051">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>JW</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Molecular structure and function of the glycine receptor chloride channel.</article-title>
                <source>Physiol Rev</source>
                <volume>84</volume>
                <fpage>1051</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">15383648</pub-id>
              </element-citation>
            </ref>
            <ref id="hyperek.REF.noebels">
              <mixed-citation publication-type="book">Noebels JL. The inherited epilepsies. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID).</italic> New York, NY: McGraw-Hill. Chap 230. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/">online</ext-link>.</mixed-citation>
            </ref>
            <ref id="hyperek.REF.tijssen.2001">
              <mixed-citation publication-type="book">Tijssen MAJ, Brown P. Channelopathies of the nervous system. In: Rose M, Griggs RC, eds. <italic toggle="yes">Hyperekplexia</italic>. Oxford, UK: Butterworth Heinemann; 2001:259-73</mixed-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="hyperek.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="hyperek.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>4 October 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>19 May 2009 (cd) Revision: sequence analysis of <italic toggle="yes">GLRB</italic> available clinically</p>
            </list-item>
            <list-item>
              <p>31 July 2007 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>6 July 2006 (sgr) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="hyperek.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Glycine receptor complexGlycine transporters (GlyTs) are members of the Na<sup>+</sup>/Cl<sup>-</sup>-dependent neurotransmitter transporter superfamily. GlyTs have dual functions at both inhibitory and excitatory synapses, resulting from the differential localization of two distinct transporters, GlyT1 and GlyT2. GlyT1 is predominantly expressed in glial cells and controls extracellular glycine concentrations in the submicromolar range for modulation of <italic toggle="yes">N</italic>-methyl-D-aspartate receptors, and also for lowering extracellular glycine levels at inhibitory glycinergic synapses. GlyT2 is found in glycinergic axons and does not display reverse uptake.Glycine receptors are ligand-gated chloride channels that cause postsynaptic hyperpolarization and synaptic inhibition in the brain stem and spinal cord. Receptors are assembled into pentameric complexes consisting of combinations of &#x003b1; and &#x003b2; subunits. The alpha-1 subunit of the inhibitory glycine receptor is located in the postsynaptic membrane of glycinergic and mixed glycinergic / GABAergic neurons.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="hyperek-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
